Ozempic and Wegovy share the common side effects of nausea and appetite loss, but there is one lesser-known risk factor that isnt mentioned nearly as often
Pancreatic Glucose Regulation and Insulin Control These medications enhance insulin secretion from pancreatic beta cells only when blood glucose levels rise, supporting a glucose-dependent response that minimizes the risk of hypoglycemia
Compounding Pharmacies Jump on Shortage Opportunity In 2022, the FDA added Eli Lillys Zepbound and Novo Nordisks Wegovyalong with their sister GLP-1s for diabetes, Mounjaro and Ozempic, respectivelyto its list of drugs in shortage, opening the door for compounding pharmacies to legally produce compounded versions for patients who were not able to source branded products
Direct and Straightforward Answers We evaluate how clinics respond to direct questions about their products and policies
Blood sugar control, particularly HbA1c reduction, can be maintained or nearly maintained when switching from low to moderate tirzepatide doses to therapeutic semaglutide doses
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed type 2 diabetes and weight management
